One Filing, Many Inventions, One Story

Filing fifteen inventions in a single U.S. nonprovisional utility application (19/540,453) is a strategic choice. Consolidated applications can reduce filing and prosecution cost compared to fifteen separate cases, and they tell a single story: an integrated technology portfolio with cross-domain coherence. Automotive, aerospace, energy, pharma, semiconductor, and defense are not random ideas; they are documented in one specification with one set of figures (1–15), one claim set, and one filing date.

For licensees and investors, that means one due-diligence target. The background section of the patent explains that existing solutions in each field “operate in isolation” and that “there is a need for a coherently documented, buildable portfolio that enables handoff, licensing, and deployment across these domains while preserving technical traceability and reproducibility.” The consolidation is part of the value proposition.

Traceability and Reproducibility

Each embodiment references defined components (e.g., DC bus, CAN, torque plates; quantum battery, thrust; Alchemy data, synthesis). The war satellite uses the same quantum battery as the electric jet; the diabetes, Alzheimer’s, and Parkinson’s methods use the same probability data system. That traceability makes it possible to build, license, or audit one embodiment without losing the links to the others. The February 13, 2026 filing date applies to all fifteen—no split priorities, no confusion.

Application # 19/540,453, Confirmation # 1134, Patent Center # 74480330. Payment receipt on file. USPTO.

Source: US Patent Application 19/540,453, Background and Summary; USPTO receipt.

Masonry view